Craig W. Lindsley, Ph.D.

Affiliations: 
2006- Pharmacology Vanderbilt University, Nashville, TN 
Website:
http://www.mc.vanderbilt.edu/labs/lindsley/lindsleycw.html
Google:
"Craig Lindsley"
Mean distance: 7.34
 
SNBCP

Children

Sign in to add trainee
Emily Jeanne Lilla research assistant 2017- Vanderbilt
Pedro Manuel Garcia-Barrantes grad student Vanderbilt
Evan P. Lebois grad student Vanderbilt (Neurotree)
Kellie D. Nance grad student Vanderbilt
Jeanette L Bertron grad student 2016- Vanderbilt
Richard Nathan Daniels grad student 2010 Vanderbilt
J. Phillip Kennedy grad student 2010 Vanderbilt
Olugbeminiyi Fadeyi grad student 2011 Vanderbilt
Leslie N. Aldrich grad student 2012 Vanderbilt
Sydney Lear Stoops grad student 2012 Vanderbilt
Michael L. Schulte grad student 2009-2013 Vanderbilt
Robert Raymond Lavieri grad student 2014 Vanderbilt
Timothy J. Senter grad student 2010-2015 Vanderbilt
Cody J. Wenthur grad student 2011-2015 Vanderbilt
Caitlin N Kent grad student 2019-2020
Kayla J. Temple post-doc 2014- Vanderbilt
Aaron T Garrison post-doc 2018-2019 Vanderbilt
Melissa Alara Korkmaz-Vaisys post-doc 2020-2021 Vanderbilt
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dwomoh L, Rossi M, Scarpa M, et al. (2022) M muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease. Science Signaling. 15: eabm3720
Luessen DJ, Gallinger IM, Ferranti AS, et al. (2022) mGlu-mediated restoration of prefrontal cortex inhibitory signaling reverses social and cognitive deficits in an NMDA hypofunction model in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Garrison AT, Orsi DL, Capstick RA, et al. (2022) Development of : A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder. Journal of Medicinal Chemistry
McClenahan SJ, Kent C, Kharade S, et al. (2022) . Molecular Pharmacology
Bertron JL, Duvernay MT, Mitchell SG, et al. (2021) Discovery and Optimization of a Novel Series of Competitive and Central Nervous System-Penetrant Protease-Activated Receptor 4 (PAR4) Inhibitors. Acs Chemical Neuroscience
Long MF, Capstick RA, Spearing PK, et al. (2021) Development of structurally distinct tricyclic M positive allosteric modulator (PAM) chemotypes - Part 2. Bioorganic & Medicinal Chemistry Letters. 128416
Yamada Y, Gilliland K, Xiang Z, et al. (2021) Positive allosteric modulators (PAMs) of the group II metabotropic glutamate receptors: Design, synthesis, and evaluation as ex-vivo tool compounds. Bioorganic & Medicinal Chemistry Letters. 128342
Kent CN, Fulton MG, Stillwell KJ, et al. (2021) Discovery and optimization of a novel CNS penetrant series of mGlu PAMs based on a 1,4-thiazepane core with in vivo efficacy in a preclinical Parkinsonian model. Bioorganic & Medicinal Chemistry Letters. 127838
Reed CW, Kalbfleisch JJ, Wong MJ, et al. (2020) Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu Positive Allosteric Modulator Tool Compound. Acs Medicinal Chemistry Letters. 11: 1773-1779
Kalbfleisch JJ, Reed CW, Park C, et al. (2020) Synthesis and SAR of a series of mGlu NAMs based on an ethyl-8-methoxy-4-(4-phenylpiperazin-1-yl)quinoline carboxylate core. Bioorganic & Medicinal Chemistry Letters. 127529
See more...